Search results for: Value-Based Pricing
Filter search results
Value-Based Pricing: OHE Comments
23 March 2011
In December 2010, the UK Department of Health released a consultation document to elicit comments on ‘proposals for a new value-based system of pricing medicines which aims to recognise and…
OHE at the ISPOR Summit on New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare October, 2018
5 November 2018
…Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals. OHE Research Paper 18/04, London: Office of Health Economics. Available at: https://www.ohe.org/publications/economics-innovative-payment-models-comparedsingle-pricing-pharmaceuticals#overlay-context=publications. Danzon P. Affordability challenges to value-based…
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…has influenced health policy and economic thinking worldwide – from value-based pricing to innovation incentives and equitable access to care. He also led OHE for over 25 years, shaping our…
Evidence on Valued Based Pricing and Reimbursement Schemes
30 September 2011
…medicines. Poster presented PPRI Conference 2011. Vienna. 29-30 September. Related OHE research: Operationalising Value Based Pricing, an OHE Research Paper. See also the posts on value-based pricing in this blog….
Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches
1 August 2011
…prices for new medicines. From January 2014, the existing Pharmaceutical Pricing Regulation Scheme (PPRS) will be replaced by “value based pricing” (VBP) for branded medicines sold to the NHS. This…
Join OHE at ISPOR: MCDA, Risk Sharing and Value-Based Pricing
4 October 2011
…in issues surrounding value-based pricing, which will become mandatory for all prescription drugs newly marketed in the UK beginning in 2014. Adrian will be a panelist in the session ‘Value…
Spotlight on OHE: Assessing Value and Balancing Needs in Health Care
15 December 2011
…Patient Access Schemes, Flexible Pricing Schemes and risk sharing schemes, all of which are becoming increasingly common approaches to shaping access to new drugs. Value based pricing (VBP), due to…
A Framework for Value-aligned Pricing of Combination Therapies
25 June 2024
…accepted pricing models in Europe represents a barrier to their access. Drawing learnings from multi-indication pricing, we propose the adoption of strategies that support combination-based differential pricing (CBDP). We outline…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 April 2012
…https://www.futuremedicine.com/doi/abs/10.2217/pme.12.99 Please cite as: Garau, M., Towse, A., Garrison, L., Housman, L. and Ossa, D., 2013. Can and should value-based pricing be applied to molecular diagnostics? Personalized Medicine, 10(1), pp.61-72….